Perimeter Medical Imaging AI to Present at Conference
Company Presentation at 2:45 p.m. ET on Tuesday, March 30, 2021 Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) (“Perimeter” or the “Company”), a medical technology...
Category : Clinical Intelligence/Clinical Efficiency
PCR Oncology Expands Offering by Adopting Deep Lens AI-Solution
PCR Oncology and Deep Lens today announced a strategic partnership that will integrate artificial intelligence-based clinical trial screening and enrollment platform, VIPER™, into the PCR Oncology network. VIPER...
AI Healthcare co. Helio Health Announces Application Acceptance
Liver cancer is the fastest growing and second deadliest cancer worldwide In China alone, more than 400,000 liver cancer diagnoses per year and nearly 100...
Optellum Receives FDA Clearance for AI Clinical Decision Software
Virtual Nodule Clinic empowers clinicians to make optimal clinical decisions in early-stage lung cancer diagnosis and is now commercially available in the United States Optellum,...
AI-enabled Platform VeriSIM Life launches PulmoSIM Therapeutics
Today, VeriSIM Life (VeriSIM) announces the launch of its pharmaceutical subsidiary, PulmoSIM Therapeutics (PulmoSIM) with the mission to address the unmet needs in the treatment...
GI OnDEMAND Announces Partnership with Ambry Genetics
Genetic Testing and Counseling Services Now Available in a Virtual Setting for Gastroenterology Practices Nationwide GI OnDEMAND ®, gastroenterology’s leading multidisciplinary virtual integrated care platform...
Lantern Pharma Files 7 Patent Applications on Novel DNA-Damaging Agent
Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence (“A.I.”) platform to transform oncology drug discovery and development today announced...
Zora Biosciences Licenses Ceramide Technology to Quest Diagnostics
Zora Biosciences Oy, a clinical diagnostics company whose mission is to identify robust markers of disease and develop them into high-throughput, health-economic value-added clinical methods,...
Brooks Participates in KeyBanc Life Sciences & MedTech Forum
Brooks Automation, Inc. (Nasdaq:BRKS) announced today that company management will participate in the KeyBanc Life Sciences & MedTech Investor Forum on Tuesday, March 23, 2021 which includes...
CuraSen Therapeutics Announces Phase 1 Clinical Data
Data Presented at the 15th International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD 21) Highlight Potential of Beta Adrenoceptor Agonists to Treat Neurodegenerative Disease CuraSen...